Chemical and Physical Characteristics of the Principal Mycotoxins

Total Page:16

File Type:pdf, Size:1020Kb

Chemical and Physical Characteristics of the Principal Mycotoxins chapter 2 . CHAPTER 2 CHAPTER Chemical and physical characteristics of the principal mycotoxins Summary try number : 1162-65-8. Molecular formu- Aflatoxin M1. CA name : (6aR,9aR)- la : C17H12O6. Molecular weight : 312.3. 2,3,6a,9a-tetrahydro-9a-hydroxy-4- This chapter provides information Aflatoxin B2. CA name : (6aR,9aS)- methoxycyclopenta[c]furo-(3′,2′:4,5]- about the chemical and physical 2,3,6a,8,9,9a-hexahydro-4-methoxy- furo[2,3-h][l]benzopyran-1,11-dione. properties of the mycotoxins consid- cyclopenta[c]furo(3′,2′:4,5]furo[2,3-h]- CAS registry number : 6795-23-9. ered in this book: aflatoxins; fumonisins; [l]benzopyran-1,11-dione. CAS registry Molecular formula : C17H12O7. Molec- ochratoxin A; trichothecenes, espe- number : 7220-81-7. Molecular formula : ular weight : 328.3. cially deoxynivalenol and nivalenol; C17H14O6. Molecular weight : 314.3. Structures of aflatoxins are shown zearalenone; and ergot alkaloids. This Aflatoxin G1. CA name : (7aR,10aS)- in Fig. 2.1. information about structures reveals 3,4,7a,10a-tetrahydro-5-methoxy-1H, the chemical diversity of mycotoxins, 12H-furo-(3′,2′:4,5]furo[2,3-h]pyrano- 1.2 Physical data which is relevant to the wide range of [3,4-c][l]benzopyran-1,12-dione. CAS toxicological effects in animals and registry number : 1165-39-5. Molecular Descriptions. Colourless to pale- humans discussed later in the book. formula : C17H12O7. Molecular weight : yellow crystals. Fluorescence in ultra- 328.3. violet (UV) light : aflatoxins B1 and 1. Aflatoxins Aflatoxin G2. CA name : (7aR,10aS)- B2, blue; aflatoxins G1 and G2, green; 3,4,7a,9,10,10a-hexahydro-5-methoxy- aflatoxin M1, blue–violet. 1.1 Formulae and structures 1H,12H-furo-(3′,2′:4,5]furo[2,3-h]pyrano- Melting-points. See Table 2.1. [3,4-c][l]benzopyran-1,12-dione.CAS Spectral properties. For UV ab- Aflatoxin B1. Chemical Abstracts (CA) registry number : 7241-98-7. Molecular sorption, see Table 2.1. Fluorescence name : (6aR,9aS)-2,3,6a,9a-tetrahydro- formula : C17H14O7. Molecular weight : excitation and emission data are 4-methoxycyclopenta[c]furo-(3′,2′:4,5]- 330.3. not listed in Table 2.1 because they furo[2,3-h][l]benzopyran-1,11-dione. depend on the type of instrument, the Chemical Abstracts Service (CAS) regis- solvent, and the supporting media Chapter 2. Chemical and physical characteristics of the principal mycotoxins 31 Fig. 2.1. Structures of aflatoxins Fumonisin B2. CA name : 1,2,3- propanetricarboxylic acid, 1,1′-[1-(12- amino-9,11-dihydroxy-2-meth- yltridecyl)-2-(1-methylpentyl)-1,2- ethanediyl] ester. CAS registry number: 116355-84-1. Molecular formula: C34H 59NO14. Molecular weight : 705. Structures of fumonisins are shown in Fig. 2.2. 2.2 Physical data Unless otherwise noted, data are from WHO (2000). Description. White hygroscopic powder. Melting-point. Not known (com- pounds have not been crystallized). Spectral properties. For mass and NMR spectral data, see Bezuidenhout et al. (1988), Laurent et al. (1989), Plattner et al. (1990), Savard and Blackwell (1994), and Cole et al. (2003a). used. For those data, see Wogan Stability. Unstable to UV light in 2.3 Chemical data (1966), Robertson and Pons (1968), the presence of oxygen. Unstable to Kiermeier and Kroczek (1974), and extremes of pH (< 3 or > 10). Unstable Solubility. Soluble in methanol, in ace- Uwaifo et al. (1977). in the presence of oxidizing agents tonitrile–water, and in water (at least For mass and nuclear magnetic (Castegnaro et al., 1980, 1991). 20 g/L) (NTP, 2001). resonance (NMR) spectral data, see Reactivity. Under alkaline condi- Stability. Stable in acetonitrile– Bycroft et al. (1970), Stubblefield et tions, the lactone ring opens and the water (1:1) at 25 °C. Unstable in meth- al. (1970), and Cole and Schweikert aflatoxins are apparently absent. anol at 25 °C, forming monomethyl (2003). However, the reaction is reversible and dimethyl esters (Gelderblom Specific rotation. [α]D in chloro- upon acidification. et al., 1992; Visconti et al., 1994). form, –558° (aflatoxin B1), –430° Ammoniation at high temperature Stable in methanol at –18 °C (aflatoxin B2), –556° (aflatoxin G1), and high pressure opens the lactone (Visconti et al., 1994). Stable in –473° (aflatoxin G2); [α]D in dimeth- ring and results in decarboxylation. buffer solutions over the pH range ylformamide, –280° (aflatoxin M1) This reaction is not reversible. 4.8–9 at 78 °C (Howard et al., 1998). (Cole and Schweikert, 2003). Octanol – water partition coeffi- 2. Fumonisins cient for fumonisin B1. log P = 1.84 1.3 Chemical data (Norred et al., 1997). 2.1 Formulae and structures Solubility. Insoluble in non-polar 3. Ochratoxin A solvents. Slightly soluble in water Fumonisin B1. CA name : 1,2,3-propane- (10–20 µg/mL). Freely soluble in tricarboxylic acid, 1, 1′-[1-(12-amino- 3.1 Formula and structure moderately polar organic solvents 4,9,11-trihydroxy-2-methyltridecyl)-2- (e.g. chloroform, methanol), espe- (1-methylpentyl)-1,2-ethanediyl] ester. Ochratoxin A. CA name : N-[(5-chlo- cially in dimethyl sulfoxide (Cole and CAS registry number : 116355-83-0. ro-3,4-dihydro-8-hydroxy-3-methyl-1- Cox, 1981; O’Neil et al., 2001). Molecular formula : C34H59NO15. Molec- oxo-1H-2-benzopyran-7-yl)carbonyl]-L- ular weight : 721. phenylalanine. CAS registry number: 32 Table 2.1. Melting-points and ultraviolet absorption of aflatoxins Ultraviolet absorption Aflatoxin Melting-point (°C) –1 –1 –3 λmax(nm) ε (L.mol .cm ) × 10 B1 268–269 (decomposition) 223 25.6 (crystals from CHCl3) 2 CHAPTER 265 13.4 362 21.8 B2 286–289 (decomposition) 265 11.7 (crystals from CHCl3–pentane) 363 23.4 G1 244–246 (decomposition) 243 11.5 (crystals from CHCl3–methanol) 257 9.9 264 10.0 362 16.1 G2 237–240 (decomposition) 265 9.7 (crystals from ethyl acetate) 363 21.0 M1 299 (decomposition) 226 23.1 (crystals from methanol) 265 11.6 357 19.0 Data from O’Neil et al. (2001). Fig. 2.2. Structures of fumonisins Chapter 2. Chemical and physical characteristics of the principal mycotoxins 33 303-47-9. Molecular formula : C 20H18ClNO6. medium (Subirade, 1996; Van der When DON was gamma- Molecular weight : 403.8. Stegen et al., 2001). irradiated on maize, breakdown of The structure of ochratoxin A Reactivity. The lactone ring DON began only after irradiation to (OTA) is shown in Fig. 2.3. opens under alkaline conditions, but 20 kGy, and 80–90% of the DON the reaction is reversible. Solutions remained after irradiation to 50 kGy 3.2 Physical data of OTA are completely degraded by (O’Neill et al., 1993). treatment with an excess of sodium No significant decomposition of Description. White odourless crys- hypochlorite. DON was observed when stored in talline solid (Pohland et al., 1982). ethyl acetate for 24 months at 25 °C Intensely fluorescent in UV light, 4. Deoxynivalenol or 3 months at 40 °C (Widestrand emitting green and blue fluorescence and Pettersson, 2001). DON was in acid and alkaline solutions, 4.1 Formula and structure relatively stable in buffer solutions respectively, due to two different over the pH range 1–10 (Lauren and forms, i.e. closed or open lactone Deoxynivalenol. CA name: 12,13-ep- Smith, 2001). ring, respectively. oxy-3,7,15-trihydroxy-(3α,7α)-trichothec- Melting-point. 159 °C when re- 9-en-8-one. CAS registry number: 5. Nivalenol crystallized from benzene–hexane 51481-10-8. Molecular formula: C15H20O6. (Natori et al., 1970); 169 °C when Molecular weight: 296.32. 5.1 Formula and structure recrystallized from xylene (Van der The structure of deoxynivalenol Merwe et al., 1965a, 1965b); 168– (DON) is shown in Fig. 2.4. Nivalenol. CA name : 12,13-epoxy- 173 °C after drying for 1 hour at 60 °C 3,4,7,15-tetrahydroxy-(3α,4β,7α)-tricho- (Pohland et al., 1982). 4.2 Physical data thec-9-en-8-one. CAS registry num- 20 Specific rotation. [α] D –118° (c = ber : 23282-20-4. Molecular formula : 1.1 mmol/L in chloroform) (Van Description. White needles. C15H20O7. Molecular weight : 312.32. der Merwe et al., 1965a, 1965b); Melting-point. 151–153 °C. The structure of nivalenol (NIV) is 21 20 [α] D –46.8° (c = 2.65 mmol/L in Specific rotation. [α] D +6.35° (c = shown in Fig. 2.4. chloroform) (Pohland et al., 1982). 0.07 mmol/L in ethanol). UV spectrum. At λmax of 214, 282, Spectral properties. IR, UV, 5.2 Physical data and 332 nm, extinction coefficients of NMR, and mass spectral data have –3 –3 37.2 × 10 , 0.89 × 10 , and 63.3 × been reported (Cole and Cox, 1981; Description. White crystals. –3 . –1. –1 10 L mol cm , respectively, have Cole et al., 2003c). Melting-point. 222 –223 °C (with been reported (Cole and Cox, 1981). decomposition, after drying in the pres- Other spectral properties. For 4.3 Chemical data ence of P2O5 at reduced pressure). 20 infrared (IR) spectra, see Van der Specific rotation. [α] D +21.54° (c = Merwe et al. (1965a, 1965b), Steyn Solubility. Soluble in chloroform, 1.3 mmol/L in ethanol). and Holzapfel (1967), and Pohland ethanol, methanol, and ethyl acetate. Spectral properties. IR, UV, NMR, et al. (1982). For NMR spectra, see Stability. Autoclaving creamed and mass spectral data have been Pohland et al. (1982) and Cole et maize reduced DON content by only reported (Cole and Cox, 1981; Brumley al. (2003b). For mass spectra, see 12% (Wolf-Hall et al., 1999). At pH et al., 1982; Cole et al., 2003c). Pohland et al. (1982) and Cole et al.
Recommended publications
  • Retention Indices for Frequently Reported Compounds of Plant Essential Oils
    Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5.
    [Show full text]
  • CAS REGISTRY: Finding CAS Registry Numbers
    STN® Quick Reference Card CAS REGISTRYSM: Finding CAS Registry Numbers® When you know the Substance Name Field Use Example /CN Use when you know the complete => E BENZOIC ACID/CN Chemical substance name. EXPAND first to => E “BICYCLO(2.2.1)HEPTANE”/CN Name determine if the name is in the database. Basic Index Use when you know segments of the => S FLUOROMETHYL name or don’t know how the name => S “2,2’” (W) BIPYRID? segments go together. => S PYRIDINE (XW) DICARBOXY? /CNS Use when you want to search for a => S ?MYCIN?/CNS Chemical Name character string embedded in a trade => S ?QUAT/CNS Segments name. Use left and right truncation to search for an embedded character string. Use when you want to require that a => S CHLOROPHENYL/CNS name segment is not part of a larger => S HEXANEDIOIC (XW) segment. DIMETHYL/CNS /HP Use when you want to restrict the search => S 1-PROPANOL/HP Heading to a Heading Parent from a CA index => S 2-PYRIDINECARBO?/HP Parent name. /INS.HP Use when you want to restrict the search => S (PYRIDINE (XW) Index Name to name segments from the Heading CARBONITRIL?)/INS.HP part of a CA index name. Segments - Parent => S FLUOROMETHYL/INS.HP Heading Parent /INS.NHP Use when you want to restrict the search => S MORPHOL?/INS.NHP Index Name to name segments from the non- => S FLUOROMETHYL/INS.NHP Segments - part of a CA index Heading-Parent Non-Heading name. Parent /ONS Use when you want to restrict the search => S VINCAM?/ONS Other Name to name segments from names other => S (INDOLE(XW)AMIN?)/ONS Segments than CA index names such as semi- systematic names, trade names, common names, etc.
    [Show full text]
  • Detoxification Strategies for Zearalenone Using
    microorganisms Review Detoxification Strategies for Zearalenone Using Microorganisms: A Review 1, 2, 1 1, Nan Wang y, Weiwei Wu y, Jiawen Pan and Miao Long * 1 Key Laboratory of Zoonosis of Liaoning Province, College of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China 2 Institute of Animal Science, Xinjiang Academy of Animal Sciences, Urumqi 830000, China * Correspondence: [email protected] or [email protected] These authors contributed equally to this work. y Received: 21 June 2019; Accepted: 19 July 2019; Published: 21 July 2019 Abstract: Zearalenone (ZEA) is a mycotoxin produced by Fusarium fungi that is commonly found in cereal crops. ZEA has an estrogen-like effect which affects the reproductive function of animals. It also damages the liver and kidneys and reduces immune function which leads to cytotoxicity and immunotoxicity. At present, the detoxification of mycotoxins is mainly accomplished using biological methods. Microbial-based methods involve zearalenone conversion or adsorption, but not all transformation products are nontoxic. In this paper, the non-pathogenic microorganisms which have been found to detoxify ZEA in recent years are summarized. Then, two mechanisms by which ZEA can be detoxified (adsorption and biotransformation) are discussed in more detail. The compounds produced by the subsequent degradation of ZEA and the heterogeneous expression of ZEA-degrading enzymes are also analyzed. The development trends in the use of probiotics as a ZEA detoxification strategy are also evaluated. The overall purpose of this paper is to provide a reliable reference strategy for the biological detoxification of ZEA. Keywords: zearalenone (ZEA); reproductive toxicity; cytotoxicity; immunotoxicity; biological detoxification; probiotics; ZEA biotransformation 1.
    [Show full text]
  • Feed Safety 2016
    Annual Report The surveillance programme for feed materials, complete and complementary feed in Norway 2016 - Mycotoxins, fungi and bacteria NORWEGIAN VETERINARY INSTITUTE The surveillance programme for feed materials, complete and complementary feed in Norway 2016 – Mycotoxins, fungi and bacteria Content Summary ...................................................................................................................... 3 Introduction .................................................................................................................. 4 Aims ........................................................................................................................... 5 Materials and methods ..................................................................................................... 5 Quantitative determination of total mould, Fusarium and storage fungi ........................................ 6 Chemical analysis .......................................................................................................... 6 Bacterial analysis .......................................................................................................... 7 Statistical analysis ......................................................................................................... 7 Results and discussion ...................................................................................................... 7 Cereals .....................................................................................................................
    [Show full text]
  • FOLIA VETERINARIA Is a Scientific Journal Issued by the University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia
    FOLIA VETERINARIA The scientific journal of the ISSN 0015-5748 UNIVERSITY OF VETERINARY MEDICINE AND eISSN PHARMACY IN KOŠICE — Slovakia 2453-7837 2 LXIV • 2020 FOLIA VETERINARIA is a scientific journal issued by the University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia. The journal is published quaterly in English (numbers 1—4) and distributed worldwide. The list of Editorial Board of scientific journal Folia Veterinaria: Editor-in-Chief: Jana Mojžišová Deputy/Managing Editor: Juraj Pistl Editorial Board: Aland, A. (Tartu, Estonia), Banhazi, T. (Toowomba, Aus- tralia), Bao, E. (Nanjing, China), Bíreš, J. (Bratislava, Slovakia), Celer, V. (Brno, Czechia), Fablet, Ch. (Ploufragan, France), Faix, Š. (Košice, Slovakia), Faixová, Z. (Košice, Slovakia), Fedoročko, P. (Košice, Slovakia), Gunnarsson, S. (Skara, Sweden), Kolacz, R. (Wrocław, Poland), Könyves, L. (Budapest, Hungary), Nagy, J. (Košice, Slovakia), Novák, M. (Bratislava, Slovakia), Paulsen, P. (Vienna, Austria), Pěchová, A. (Brno, Czechia), Sossidou, E. N. (Thermi Thessa- loniki, Greece), Večerek, V. (Brno, Czechia), Vorlová, V. (Brno, Czechia) Vargová, M. — technical editor (Košice, Slovakia) Contact: tel.: +421 915 984 669 e-mail: [email protected] Electronic Publisher: De Gruyter Poland, Bogumila Zuga 32A 01-811 Warsaw, Poland ISSN 2453-7837 on-line ISSN 0015-5748 print EV 3485/09 Publisher’s Identification number: IČO 00397474 June 2020 FOLIA VETERINARIA PUBLISHED BY THE UNIVERSITY OF VETERINARY MEDICINE AND PHARMACY IN KOŠICE SLOVAK IA Folia Veterinaria Vol. 64, 2, 2020 V YDÁVA UNIVERZITA VETERINÁRSKEHO LEKÁRSTVA A FARMÁCIE V KOŠICIACH 2020 F O L I A V E T E R I N A R I A, 64, 2, 2020 C O N T E N T S ADESOKAN, H.
    [Show full text]
  • REGISTRY Database Summary Sheet (DBSS)
    SM REGISTRY/ZREGISTRY (CAS REGISTRY ) Subject • All types of inorganic and organic substances, including alloys, coordination Coverage compounds, minerals, mixtures, polymers, salts, high throughput screening (HTS) compounds as well as nucleic acid and protein sequences • Substances included in REGISTRY meet the following criteria: - Identified by CAS as coming from a reputable source, including but not limited to patents, journals, chemical catalogs, and selected substance collections on the web - Described in largely unambiguous terms - Characterized by physical methods or described in a patent document example or claim - Consistent with the laws of atomic covalent organization • Experimental and predicted property data and tags and spectra data File Type Numeric, Structure Features Alerts (SDIs) Biweekly In addition, SMARTracker, an automatic crossfile current-awareness search, (SDI XFILE) using a REGISTRY search profile in CA, HCA, ZCA, CAplus, HCAplus or ZCAplus may be run weekly or biweekly (weekly is the default). CAS Registry Keep & Share SLART Number® Identifiers ® Learning Database STN Easy Structures Record • CAS Registry Numbers • Experimental and predicted property Content • CA index names and commonly used data and tags chemical names and trade names • Spectra • Molecular formulas • List of databases and regulatory listings • Structure diagrams containing information on the substances • Sequence data • Super roles and document type SM • Alloy composition tables information from CAplus • Classes for polymers • Displayable information for 10 most recent references for substances • Ring analysis data File Size More than 140 million organic and inorganic substances; more than 71.1 million sequences (4/18) Coverage Early 1800s to the present Updates Daily Language English Database Chemical Abstracts Service Producer 2540 Olentangy River Road P.O.
    [Show full text]
  • Evaluation of the Individual and Combined Toxicity of Fumonisin Mycotoxins in Human Gastric Epithelial Cells
    International Journal of Molecular Sciences Article Evaluation of the Individual and Combined Toxicity of Fumonisin Mycotoxins in Human Gastric Epithelial Cells Song Yu, Bingxuan Jia, Na Liu, Dianzhen Yu and Aibo Wu * SIBS-UGENT-SJTU Joint Laboratory of Mycotoxin Research, CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; [email protected] (S.Y.); [email protected] (B.J.); [email protected] (N.L.); [email protected] (D.Y.) * Correspondence: [email protected]; Tel.: +86-21-54920716 Received: 23 July 2020; Accepted: 14 August 2020; Published: 18 August 2020 Abstract: Fumonisin contaminates food and feed extensively throughout the world, causing chronic and acute toxicity in human and animals. Currently, studies on the toxicology of fumonisins mainly focus on fumonisin B1 (FB1). Considering that FB1, fumonisin B2 (FB2) and fumonisin B3 (FB3) could coexist in food and feed, a study regarding a single toxin, FB1, may not completely reflect the toxicity of fumonisin. The gastrointestinal tract is usually exposed to these dietary toxins. In our study, the human gastric epithelial cell line (GES-1) was used as in vitro model to evaluate the toxicity of fumonisin. Firstly, we found that they could cause a decrease in cell viability, and increase in membrane leakage, cell death and the induction of expression of markers for endoplasmic reticulum (ER) stress. Their toxicity potency rank is FB1 > FB2 >> FB3. The results also showed that the synergistic effect appeared in the combinations of FB1 + FB2 and FB1 + FB3.
    [Show full text]
  • Overview and Status of EPA Collaborations for Detection of Selected Biotoxins in Drinking Water, Soils, and Wipes
    Overview and Status of EPA collaborations for Detection of Selected Biotoxins in Drinking Water, Soils, and Wipes Matthew L. Magnuson, Ph.D. US Environmental Protection Agency National Homeland Security Research Center Office of Research and Development NHSRC Mission To conduct research and develop scientific products that improve the capability of the Agency to carry out its homeland security responsibilities ADVANCING OUR NATION’S SECURITY THROUGH SCIENCE Office of Research and Development NHSRC Research Projects Homeland Security Multi Use Cross agency “Normal” Environmental Operations Many homeland security practices may also benefit day to day operation. For example, emerging analytical techniques to monitor water quality might be used during other water emergencies and/or clean-up after contamination. Office of Research and Development NHSRC Products • 125 reports and journal articles since 2003 (including classified) • Results presented many other ways—stakeholder meetings, symposia, workshops, etc. • Products and research plans receive rigorous quality reviews Most scientists regarded the new streamlined peer-review process as ‘quite an improvement.’ Office of Research and Development Overview of Detection of Biotoxins • Laboratory methods – SAM method compendium – Collaborative projects – Future directions Office of Research and Development Laboratory methods • Method development and study – Documentation: Methods and study reports • Methods aim to have DQOs fit for their intended use by – EPA/Water Security Division through
    [Show full text]
  • Chemical Name Federal P Code CAS Registry Number Acutely
    Acutely / Extremely Hazardous Waste List Federal P CAS Registry Acutely / Extremely Chemical Name Code Number Hazardous 4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro- P059 76-44-8 Acutely Hazardous 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide P050 115-29-7 Acutely Hazardous Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- P197 17702-57-7 Acutely Hazardous 1-(o-Chlorophenyl)thiourea P026 5344-82-1 Acutely Hazardous 1-(o-Chlorophenyl)thiourea 5344-82-1 Extremely Hazardous 1,1,1-Trichloro-2, -bis(p-methoxyphenyl)ethane Extremely Hazardous 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4-metheno-1H-cyclobuta (cd) pentalene, Dechlorane Extremely Hazardous 1,1a,3,3a,4,5,5,5a,5b,6-Decachloro--octahydro-1,2,4-metheno-2H-cyclobuta (cd) pentalen-2- one, chlorecone Extremely Hazardous 1,1-Dimethylhydrazine 57-14-7 Extremely Hazardous 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4,4a,5,6,7,8,8a-octahydro-1,4-endo-endo-5,8- dimethanonaph-thalene Extremely Hazardous 1,2,3-Propanetriol, trinitrate P081 55-63-0 Acutely Hazardous 1,2,3-Propanetriol, trinitrate 55-63-0 Extremely Hazardous 1,2,4,5,6,7,8,8-Octachloro-4,7-methano-3a,4,7,7a-tetra- hydro- indane Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]- 51-43-4 Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, P042 51-43-4 Acutely Hazardous 1,2-Dibromo-3-chloropropane 96-12-8 Extremely Hazardous 1,2-Propylenimine P067 75-55-8 Acutely Hazardous 1,2-Propylenimine 75-55-8 Extremely Hazardous 1,3,4,5,6,7,8,8-Octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime 26419-73-8 Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime.
    [Show full text]
  • | Hao Wanatha Maria Del Contatta Datum
    |HAO WANATHA MARIAUS009844679B2 DEL CONTATTA DATUM (12 ) United States Patent ( 10 ) Patent No. : US 9 ,844 , 679 B2 Nayfach - Battilana ( 45 ) Date of Patent : * Dec . 19 , 2017 (54 ) NANOPARTICLE - SIZED MAGNETIC (56 ) References Cited ABSORPTION ENHANCERS HAVING THREE - DIMENSIONAL GEOMETRIES U . S . PATENT DOCUMENTS ADAPTED FOR IMPROVED DIAGNOSTICS 4 , 106 ,488 A 8 / 1978 Gordon AND HYPERTHERMIC TREATMENT 4 ,303 ,636 A 12/ 1981 Gordon ( 71 ) Applicant: Qteris, Inc. , San Rafael, CA (US ) ( Continued ) ( 72 ) Inventor : Joseph N . Nayfach - Battilana , San FOREIGN PATENT DOCUMENTS Rafael , CA (US ) EP 0040512 B1 11 / 1981 EP 0136530 A16 /1988 (73 ) Assignee : Qteris, Inc. , San Rafael , CA (US ) (Continued ) ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 OTHER PUBLICATIONS U . S . C . 154 ( b ) by 903 days. “ Krishna et al ., Unusual size -dependent magnetization in near This patent is subject to a terminal dis hemispherical Co nanomagnets on SiO . sub . 2 from fast pulsed laser claimer . processing” , J . Appl. Phys. 103 , 073902 (2008 ) (“ Krishna ” ) .* (Continued ) ( 21 ) Appl . No .: 14 /044 , 251 Primary Examiner — Joseph Stoklosa (22 ) Filed : Oct. 2 , 2013 Assistant Examiner — Adam Avigan (74 ) Attorney , Agent, or Firm — Marek Alboszta (65 ) Prior Publication Data US 2014 /0172049 A1 Jun . 19 , 2014 (57 ) ABSTRACT Nanoparticle- sized magnetic absorption enhancers (MAES ) Related U . S . Application Data exhibiting a controlled response to a magnetic field , includ ing a controlled mechanical response and an inductive (62 ) Division of application No . 12 /925 ,904 , filed on Nov. thermal response . The MAEs have a magnetic material that 1 , 2010 , now Pat .
    [Show full text]
  • Rope Parasite” the Rope Parasite Parasites: Nearly Every AuSC Child I Ever Treated Proved to Carry a Significant Parasite Burden
    Au#sm: 2015 Dietrich Klinghardt MD, PhD Infec4ons and Infestaons Chronic Infecons, Infesta#ons and ASD Infec4ons affect us in 3 ways: 1. Immune reac,on against the microbes or their metabolic products Treatment: low dose immunotherapy (LDI, LDA, EPD) 2. Effects of their secreted endo- and exotoxins and metabolic waste Treatment: colon hydrotherapy, sauna, intes4nal binders (Enterosgel, MicroSilica, chlorella, zeolite), detoxificaon with herbs and medical drugs, ac4vaon of detox pathways by solving underlying blocKages (methylaon, etc.) 3. Compe,,on for our micronutrients Treatment: decrease microbial load, consider vitamin/mineral protocol Lyme, Toxins and Epigene#cs • In 2000 I examined 10 au4s4c children with no Known history of Lyme disease (age 3-10), with the IgeneX Western Blot test – aer successful treatment. 5 children were IgM posi4ve, 3 children IgG, 2 children were negave. That is 80% of the children had clinical Lyme disease, none the history of a 4cK bite! • Why is it taking so long for au4sm-literate prac44oners to embrace the fact, that many au4s4c children have contracted Lyme or several co-infec4ons in the womb from an oVen asymptomac mother? Why not become Lyme literate also? • Infec4ons can be treated without the use of an4bio4cs, using liposomal ozonated essen4al oils, herbs, ozone, Rife devices, PEMF, colloidal silver, regular s.c injecons of artesunate, the Klinghardt co-infec4on cocKtail and more. • Symptomac infec4ons and infestaons are almost always the result of a high body burden of glyphosate, mercury and aluminum - against the bacKdrop of epigene4c injuries (epimutaons) suffered in the womb or from our ancestors( trauma, vaccine adjuvants, worK place related lead, aluminum, herbicides etc., electromagne4c radiaon exposures etc.) • Most symptoms are caused by a confused upregulated immune system (molecular mimicry) Toxins from a toxic environment enter our system through damaged boundaries and membranes (gut barrier, blood brain barrier, damaged endothelium, etc.).
    [Show full text]
  • Aflatoxin B1 in Human Serum Issn 0025-7680313
    AFLATOXIN B1 IN HUMAN SERUM ISSN 0025-7680313 ORIGINAL ARTICLE MEDICINA (Buenos Aires) 2002; 62: 313-316 AFLATOXIN B1 CONTENT IN PATIENTS WITH HEPATIC DISEASES CLARA LOPEZ, LAURA RAMOS, LUCIA BULACIO, SILVANA RAMADAN, FERNANDA RODRIGUEZ Centro de Referencia de Micología (CEREMIC). Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario Abstract Aflatoxins are toxic metabolites of some Aspergillus flavus, A. parasiticus and A. nomius strains that occur in many foods and feeds. There are four major natural occurring aflatoxins: B1, B2, G1 and G2. These toxins can cause illness in human beings and animals. Aflatoxin B1 is the most abundant and toxic member of the family, and it is also the most potent hepatocarcinogen known. In order to estimate the potential human health risk of AFB1, it is useful to measure blood concentration. The presence of aflatoxin B1 in patients was evaluated by high-performance liquid chromatography, in serum samples, obtained from 20 patient volunteers with hepatic disease. Out of the 20 patients, the presence of AFB1 was detected in only one of them, in a concentration of 0.47 ng/cm3. Nevertheless, this result should draw the attention of control organizations in Argentina to the need for a thorough food and feed inspection. Key words: aflatoxin B1, hepatic diseases,serum samples, HPLC Resumen Aflatoxina B1 en pacientes con enfermedades hep·ticas. Las aflatoxinas son metabolitos tóxicos producidos por cepas de Aspergillus flavus, A. parasiticus y A. nomius, presentes en alimentos y piensos. Las cuatro aflatoxinas principales son: aflatoxina B1, B2, G1 y G2. Dichas toxinas pueden causar enfermedades tanto en seres humanos como en animales.
    [Show full text]